SEARCH      advanced search  help  site index 12 May 2008

Journal   Home   Current issue   Previous issue   Advance Online Publication   Archive   Author index   Keyword index   Aims & scope   Editors & editorial board   Contacts   Web focus For authors   Submitting to BJC   Author Licence Services   Receive Table of Contents by email   Online sample copy FREE   Order sample copy   Recommend to your library   Prices   Indexed in   Purchasing articles   Reprints & permissions   For advertisers   Press releases   About nature publishing group		Vol 98, No 9 (May 2008) ISSN 0007-0920 Multidisciplinary Journal of Cancer Research BJC publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients. BJC is proud of its editorial independence, high standards, and tradition of serving the international cancer research community - we are one of the world's leading general cancer journals and our impact factor currently stands at 4.459, ranking 33/127 for Oncology. Web Focus: New targets for cancer therapy Showcasing some of the most cited recent minireviews, this new collection focuses on key pathways and targets for new therapeutics, including the IGF pathway, rapamycin and mTOR signalling, the EGFR pathway, epigenetics and microRNAs. Click here to view the minireviews collection. Featured articles   The role of early life genistein exposures in modifying breast cancer risk   Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model   Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias   Perinatal risk factors for hepatoblastoma   Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition   The role of S-1 in the treatment of gastric cancer   A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours   VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy   ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen   Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53   Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer   Does smoking among friends explain apparent genetic effects on current smoking in adolescence and young adulthood?   Table of Contents in full		NPG Resources Nature Cancer Update Nature News NPG titles by subject Naturejobs Natureevents
Print ISSN: 0007-0920 | Online ISSN: 1532-1827 © 2008 Cancer Research UK Privacy Policy